An investigational autoinjector device for administering Zilbrysq (zilucoplan), an approved therapy for generalized myasthenia gravis (gMG), is a…
Articles by Marisa Wexler, MS
Cemdisiran, an experimental therapy given by injection under the skin every three months, was shown to significantly and sustainably…
Kyverna Therapeutics’ experimental cell therapy KYV-101, now called mivocabtagene autoleucel (miv-cel), was associated with rapid, sustained symptom improvements…
Zilbrysq (zilucoplan) helped ease disease symptoms and improve quality of life for most people with generalized myasthenia gravis…
A late-stage clinical trial testing KYV-101, a CAR T-cell therapy for adults with hard-to-treat generalized myasthenia gravis (gMG),…
The immunosuppressive medications azathioprine and mycophenolate mofetil are similarly effective at controlling symptoms of generalized myasthenia gravis (gMG), but…
Cartesian Therapeutics’ experimental cell therapy Descartes-08 outperformed a placebo at easing symptoms of generalized myasthenia gravis (gMG) in…
Rystiggo (rozanolixizumab-noli) provides consistent symptom relief for people with generalized myasthenia gravis (gMG) across more than a dozen…
Johnson & Johnson (J&J) has launched a Phase 3b clinical trial to compare the efficacy of two approved treatments…
Uplizna (inebilizumab), Amgen’s infusion therapy for adults with generalized myasthenia gravis (gMG) who are positive for antibodies targeting…